1627 related articles for article (PubMed ID: 8605733)
1. Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones.
van Golen KL; Risin S; Staroselsky A; Berger D; Tainsky MA; Pathak S; Price JE
Clin Exp Metastasis; 1996 Mar; 14(2):95-106. PubMed ID: 8605733
[TBL] [Abstract][Full Text] [Related]
2. Metastatic phenotype of mouse-human melanoma cell hybrids is associated with the presence of chromosome 17 from highly metastatic human melanoma cells.
Risin S; Vangolen K; Price J; Pathak S
Int J Oncol; 1996 Aug; 9(2):225-34. PubMed ID: 21541504
[TBL] [Abstract][Full Text] [Related]
3. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.
Radinsky R; Weisberg HZ; Staroselsky AN; Fidler IJ
Cancer Res; 1992 Oct; 52(20):5808-14. PubMed ID: 1394207
[TBL] [Abstract][Full Text] [Related]
4. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma.
Staroselsky AH; Pathak S; Chernajovsky Y; Tucker SL; Fidler IJ
Cancer Res; 1991 Dec; 51(23 Pt 1):6292-8. PubMed ID: 1834329
[TBL] [Abstract][Full Text] [Related]
5. Expression of the tumor metastatic suppressor gene in mouse melanoma model: inverse association to metastatic potential.
Meng L
J Tongji Med Univ; 1998; 18(1):28-32, 36. PubMed ID: 10806798
[TBL] [Abstract][Full Text] [Related]
6. Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials.
Hamby CV; Mendola CE; Potla L; Stafford G; Backer JM
Biochem Biophys Res Commun; 1995 Jun; 211(2):579-85. PubMed ID: 7794272
[TBL] [Abstract][Full Text] [Related]
7. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
[TBL] [Abstract][Full Text] [Related]
8. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.
Baba H; Urano T; Okada K; Furukawa K; Nakayama E; Tanaka H; Iwasaki K; Shiku H
Cancer Res; 1995 May; 55(9):1977-81. PubMed ID: 7728768
[TBL] [Abstract][Full Text] [Related]
9. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.
MacDonald NJ; De la Rosa A; Benedict MA; Freije JM; Krutsch H; Steeg PS
J Biol Chem; 1993 Dec; 268(34):25780-9. PubMed ID: 8245015
[TBL] [Abstract][Full Text] [Related]
10. Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells.
Parhar RS; Shi Y; Zou M; Farid NR; Ernst P; al-Sedairy ST
Int J Cancer; 1995 Jan; 60(2):204-10. PubMed ID: 7829217
[TBL] [Abstract][Full Text] [Related]
11. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.
Leone A; Flatow U; King CR; Sandeen MA; Margulies IM; Liotta LA; Steeg PS
Cell; 1991 Apr; 65(1):25-35. PubMed ID: 2013093
[TBL] [Abstract][Full Text] [Related]
12. Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
Huijzer JC; McFarland M; Niles RM; Meadows GG
J Cell Physiol; 1996 Mar; 166(3):487-94. PubMed ID: 8600152
[TBL] [Abstract][Full Text] [Related]
13. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
[TBL] [Abstract][Full Text] [Related]
14. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11.
Rinker-Schaeffer CW; Hawkins AL; Ru N; Dong J; Stoica G; Griffin CA; Ichikawa T; Barrett JC; Isaacs JT
Cancer Res; 1994 Dec; 54(23):6249-56. PubMed ID: 7954474
[TBL] [Abstract][Full Text] [Related]
15. Differential nm23 gene expression at the fetal-maternal interface.
Shi Y; Parhar RS; Zou M; al-Sedairy S; Farid NR
Br J Cancer; 1994 Sep; 70(3):440-4. PubMed ID: 8080727
[TBL] [Abstract][Full Text] [Related]
16. Expression of NM23 in human melanoma progression and metastasis.
Easty DJ; Maung K; Lascu I; Véron M; Fallowfield ME; Hart IR; Bennett DC
Br J Cancer; 1996 Jul; 74(1):109-14. PubMed ID: 8679442
[TBL] [Abstract][Full Text] [Related]
17. Modulators of intracellular Ca2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma.
Parker C; Sherbet GV
Melanoma Res; 1992 Dec; 2(5-6):337-43. PubMed ID: 1337998
[TBL] [Abstract][Full Text] [Related]
18. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.
Miele ME; Robertson G; Lee JH; Coleman A; McGary CT; Fisher PB; Lugo TG; Welch DR
Mol Carcinog; 1996 Apr; 15(4):284-99. PubMed ID: 8634087
[TBL] [Abstract][Full Text] [Related]
19. Localization of a second NM23 gene, NME2, to chromosome 17q21-q22.
Kelsell DP; Black DM; Solomon E; Spurr NK
Genomics; 1993 Aug; 17(2):522-4. PubMed ID: 8406509
[TBL] [Abstract][Full Text] [Related]
20. Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate.
Goldberg SF; Harms JF; Quon K; Welch DR
Clin Exp Metastasis; 1999; 17(7):601-7. PubMed ID: 10845559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
